Voyager Therapeutics, Inc. (VYGR)
3.42
-0.03
(-0.87%)
USD |
NASDAQ |
Sep 01, 16:00
3.42
0.00 (0.00%)
After-Hours: 18:49
Voyager Therapeutics Price to Book Value : 1.357 for Sept. 1, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 31, 2026 | 1.369 |
| August 28, 2026 | 1.405 |
| August 27, 2026 | 1.373 |
| August 26, 2026 | 1.373 |
| August 25, 2026 | 1.381 |
| August 24, 2026 | 1.365 |
| August 21, 2026 | 1.346 |
| August 20, 2026 | 1.318 |
| August 19, 2026 | 1.354 |
| August 18, 2026 | 1.310 |
| August 17, 2026 | 1.282 |
| August 14, 2026 | 1.298 |
| August 13, 2026 | 1.278 |
| August 12, 2026 | 1.270 |
| August 11, 2026 | 1.270 |
| August 10, 2026 | 1.258 |
| August 07, 2026 | 1.298 |
| August 06, 2026 | 1.242 |
| August 05, 2026 | 1.230 |
| August 04, 2026 | 1.240 |
| August 03, 2026 | 1.191 |
| July 31, 2026 | 1.203 |
| July 30, 2026 | 1.242 |
| July 29, 2026 | 1.191 |
| July 28, 2026 | 1.207 |
| Date | Value |
|---|---|
| July 27, 2026 | 1.226 |
| July 24, 2026 | 1.230 |
| July 23, 2026 | 1.226 |
| July 22, 2026 | 1.230 |
| July 21, 2026 | 1.246 |
| July 20, 2026 | 1.211 |
| July 17, 2026 | 1.258 |
| July 16, 2026 | 1.207 |
| July 15, 2026 | 1.270 |
| July 14, 2026 | 1.254 |
| July 13, 2026 | 1.286 |
| July 10, 2026 | 1.365 |
| July 09, 2026 | 1.461 |
| July 08, 2026 | 1.480 |
| July 07, 2026 | 1.500 |
| July 06, 2026 | 1.437 |
| July 02, 2026 | 1.500 |
| July 01, 2026 | 1.429 |
| June 30, 2026 | 1.389 |
| June 29, 2026 | 1.243 |
| June 26, 2026 | 1.247 |
| June 25, 2026 | 1.233 |
| June 24, 2026 | 1.278 |
| June 23, 2026 | 1.285 |
| June 22, 2026 | 1.292 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 20.26 |
| Anika Therapeutics, Inc. | 2.066 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.764 |
Price to Book Value Related Metrics
| PS Ratio | 5.900 |
| Price | 3.42 |
| Earnings Yield | -53.02% |
| Market Cap | 209.55M |